publication . Other literature type . Article . 2018

Increased T cell trafficking as adjunct therapy for HIV-1.

Helen R. Fryer; Steven M. Wolinsky; Angela R. McLean;
  • Published: 01 Mar 2018
  • Publisher: Public Library of Science (PLoS)
  • Country: United Kingdom
Author summary Despite the success of potent antiretroviral therapy in suppressing the amount of virus in peripheral blood for long periods of time, a reservoir of infectious virus persists in CD4 T cells, implying the need for long-term treatment. Strategies to control and ultimately eliminate the viral reservoir within specific tissue compartments will need to target virus that persists in both a long-lived reservoir of infectious virus in CD4 T cells as well as low-levels of viral replication that continues despite antiretroviral drug therapy. Using a mathematical model, we describe a hypothetical new therapeutic approach to eliminating HIV-1 persistence in t...
free text keywords: Research Article, Biology and Life Sciences, Immunology, Vaccination and Immunization, Antiviral Therapy, Antiretroviral Therapy, Medicine and Health Sciences, Public and Occupational Health, Preventive Medicine, Cell Biology, Cellular Types, Animal Cells, Blood Cells, White Blood Cells, T Helper Cells, Immune Cells, Microbiology, Virology, Viral Replication, Medical Microbiology, Microbial Pathogens, Viral Pathogens, Immunodeficiency Viruses, HIV, HIV-1, Pathology and Laboratory Medicine, Pathogens, Organisms, Viruses, RNA viruses, Retroviruses, Lentivirus, T Cells, Pharmacology, Drugs, Antimicrobials, Antivirals, Antiretrovirals, Microbial Control, Viral Persistence and Latency, Anatomy, Lymphatic System, Lymphoid Tissue, Biology (General), QH301-705.5, Ecology, Modelling and Simulation, Computational Theory and Mathematics, Genetics, Ecology, Evolution, Behavior and Systematics, Molecular Biology, Cellular and Molecular Neuroscience, Bioinformatics, T cell, medicine.anatomical_structure, medicine, Disease reservoir, Virus latency, medicine.disease, Biology, Viral load, Adjunct
Related Organizations
Funded by
  • Funder: National Institutes of Health (NIH)
  • Project Code: 5U01AI035039-15
NIH| A Systems-level Approach to Studying HIV/AIDS Susceptibility and Substance Abuse
  • Funder: National Institutes of Health (NIH)
  • Project Code: 1R01DA033773-01
63 references, page 1 of 5

1 Perelson AS, Essunger P, Cao Y, Vesanen M, Hurley A, et al (1997) Decay characteristics of HIV-1-infected compartments during combination therapy. Nature 387: 188–191. doi: 10.1038/387188a0 9144290 [OpenAIRE] [PubMed]

2 Chun TW, Carruth L, Finzi D, Shen X, DiGiuseppe JA, et al (1997) Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 387: 183–188. doi: 10.1038/387183a0 9144289 [OpenAIRE] [PubMed]

3 Finzi D, Blankson J, Siliciano JD, Margolick JB, Chadwick K, et al (1999) Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nat Med 5: 512–517. doi: 10.1038/8394 10229227 [OpenAIRE] [PubMed]

4 Finzi D, Hermankova M, Pierson T, Carruth LM, Buck C, et al (1997) Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 278: 1295–1300. 9360927 [OpenAIRE] [PubMed]

5 Wong JK, Hezareh M, Gunthard HF, Havlir DV, Ignacio CC, et al (1997) Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science 278: 1291–1295. 9360926 [OpenAIRE] [PubMed]

6 Furtado MR, Callaway DS, Phair JP, Kunstman KJ, Stanton JL, et al (1999) Persistence of HIV-1 transcription in peripheral-blood mononuclear cells in patients receiving potent antiretroviral therapy. N Engl J Med 340: 1614–1622. doi: 10.1056/NEJM199905273402102 10341273 [OpenAIRE] [PubMed]

7 Thompson CG, Gay CL, Kashuba ADM (2017) HIV Persistence in Gut-Associated Lymphoid Tissues: Pharmacological Challenges and Opportunities. AIDS Res Hum Retroviruses 33: 513–523. doi: 10.1089/AID.2016.0253 28398774 [OpenAIRE] [PubMed]

8 Bruner KM, Murray AJ, Pollack RA, Soliman MG, Laskey SB, et al (2016) Defective proviruses rapidly accumulate during acute HIV-1 infection. Nat Med 22: 1043–1049. doi: 10.1038/nm.4156 27500724 [OpenAIRE] [PubMed]

9 Chun TW, Stuyver L, Mizell SB, Ehler LA, Mican JA, et al (1997) Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc Natl Acad Sci U S A 94: 13193–13197. 9371822 [OpenAIRE] [PubMed]

10 Davey RT Jr., Bhat N, Yoder C, Chun TW, Metcalf JA, et al (1999) HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression Proc Natl Acad Sci U S A 96: 15109–15114. 10611346 [OpenAIRE] [PubMed]

11 Siliciano JD, Kajdas J, Finzi D, Quinn TC, Chadwick K, et al (2003) Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells. Nat Med 9: 727–728. doi: 10.1038/nm880 12754504 [OpenAIRE] [PubMed]

12 Chomont N, El-Far M, Ancuta P, Trautmann L, Procopio FA, et al (2009) HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation. Nat Med 15: 893–900. doi: 10.1038/nm.1972 19543283 [OpenAIRE] [PubMed]

13 Lorenzo-Redondo R, Fryer HR, Bedford T, Kim EY, Archer J, et al (2016) Persistent HIV-1 replication maintains the tissue reservoir during therapy. Nature 530: 51–56. doi: 10.1038/nature16933 26814962 [OpenAIRE] [PubMed]

14 Martin ez-Picado J, Deeks SG (2016) Persistent HIV-1 replication during antiretroviral therapy. Curr Opin HIV AIDS 11: 417–423. doi: 10.1097/COH.0000000000000287 27078619 [OpenAIRE] [PubMed]

15 Fletcher CV, Staskus K, Wietgrefe SW, Rothenberger M, Reilly C, et al (2014) Persistent HIV-1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissues. Proc Natl Acad Sci U S A 111: 2307–2312. doi: 10.1073/pnas.1318249111 24469825 [OpenAIRE] [PubMed]

63 references, page 1 of 5
Powered by OpenAIRE Research Graph
Any information missing or wrong?Report an Issue